Clincosm LogoSign in Get a demo

Melanoma

Showing NaN - NaN of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Sarcoma, Melanoma, Lung Cancer Trial in United States (PRT1419)

Recruiting
  • Sarcoma
  • +6 more
  • Denver, Colorado
  • +6 more
May 26, 2022

Unresectable And Metastatic Melanoma: The Optimize Study

Completed
  • Melanoma
    • Muscle Shoals, Alabama
    • +65 more
    May 17, 2022

    Cancer, Melanoma Trial in Worldwide (drug, biological, other)

    Recruiting
    • Cancer
    • Melanoma
    • Springdale, Arkansas
    • +70 more
    May 16, 2022

    Melanoma Stage III, Melanoma Trial in Durham, Philadelphia (nivolumab, Ipilimumab)

    Recruiting
    • Melanoma Stage III
    • Melanoma
    • Durham, North Carolina
    • +1 more
    Mar 25, 2022

    Melanoma Trial in United States (MGA271)

    Terminated
    • Melanoma
    • MGA271
    • Los Angeles, California
    • +6 more
    Feb 4, 2022

    Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

    Completed
    • Prostate Cancer
    • +6 more
    • MGA271
    • Los Angeles, California
    • +11 more
    Feb 4, 2022

    Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

    Terminated
    • Mesothelioma
    • +12 more
    • MGD009
    • Los Angeles, California
    • +19 more
    Feb 4, 2022

    Melanoma Trial in Canada, United States (POL-103A, POL-103A without API)

    Terminated
    • Melanoma
    • POL-103A
    • POL-103A without API
    • Chandler, Arizona
    • +64 more
    Dec 6, 2021

    Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma Trial in Spain, United States (APX005M, Nivolumab)

    Completed
    • Cancer
    • +4 more
    • Tucson, Arizona
    • +22 more
    Dec 3, 2021

    Melanoma Trial in United States (Ipilimumab, Nivolumab)

    Completed
    Has Results
    • Melanoma
    • Duarte, California
    • +35 more
    Sep 8, 2021

    Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

    Completed
    • Melanoma
    • +3 more
    • Enoblituzumab
    • +2 more
    • Scottsdale, Arizona
    • +19 more
    Sep 22, 2021

    Melanoma Trial in Philadelphia (Nivolumab, Hydroxychloroquine, Ipilimumab)

    Recruiting
    • Melanoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Sep 15, 2021

    Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

    Completed
    • Clear Cell Renal Cell Carcinoma (ccRCC)
    • +2 more
    • Scottsdale, Arizona
    • +16 more
    Aug 16, 2021

    Melanoma Trial in United States (TAK-580, TAK-202, vedolizumab)

    Terminated
    Has Results
    • Melanoma
    • Tucson, Arizona
    • +13 more
    Mar 3, 2021

    Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

    Terminated
    Has Results
    • Melanoma
    • GSK 2132231A
    • Placebo
    • Birmingham, Alabama
    • +256 more
    Feb 5, 2021

    Melanoma Trial in United States (ipilimumab, nivolumab)

    Completed
    Has Results
    • Melanoma
    • Los Angeles, California
    • +6 more
    Feb 2, 2021

    Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

    Completed
    Has Results
    • Melanoma
    • Scottsdale, Arizona
    • +120 more
    Feb 8, 2021

    Melanoma, Head and Neck Squamous Cell Carcinoma, Solid Tumor Trial in Philadelphia, Pittsburgh, Houston (SB 11285, Atezolizumab)

    Recruiting
    • Melanoma
    • +2 more
    • Philadelphia, Pennsylvania
    • +2 more
    Dec 21, 2020

    Urothelial Carcinoma, Head Neck Cancer, Melanoma Trial in Canada, Spain, United States (Autologous genetically modified MAGE

    Completed
    • Urothelial Carcinoma
    • +3 more
    • Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells
    • Boston, Massachusetts
    • +10 more
    Dec 17, 2020

    Melanoma Trial in Worldwide (Immunotherapeutic GSK2132231A)

    Completed
    Has Results
    • Melanoma
    • Immunotherapeutic GSK2132231A
    • Los Angeles, California
    • +62 more
    Dec 7, 2020

    Multiple Myeloma, Melanoma, Synovial Sarcoma Trial in Philadelphia (biological, drug, device)

    Terminated
    • Multiple Myeloma
    • +3 more
    • NY-ESO-1 redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Oct 9, 2020

    Melanoma Trial in Worldwide (pembrolizumab + epacadostat, pembrolizumab + )

    Completed
    Has Results
    • Melanoma
    • pembrolizumab + epacadostat
    • pembrolizumab + placebo
    • Birmingham, Alabama
    • +128 more
    Aug 14, 2020

    Melanoma, Metastatic Melanoma, Solid Tumor Trial in United Kingdom, United States (MLN2480)

    Completed
    Has Results
    • Melanoma
    • +3 more
    • San Francisco, California
    • +15 more
    Jul 28, 2020